Form 8-K - Current report:
SEC Accession No. 0001493152-24-041363
Filing Date
2024-10-17
Accepted
2024-10-17 08:50:32
Documents
15
Period of Report
2024-10-16
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41303
2 ex99-1.htm EX-99.1 13667
3 ex99-1_001.jpg GRAPHIC 755190
  Complete submission text file 0001493152-24-041363.txt   1274814

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE sonn-20241016.xsd EX-101.SCH 3018
5 XBRL LABEL FILE sonn-20241016_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE sonn-20241016_pre.xml EX-101.PRE 24167
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3700
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

EIN.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35570 | Film No.: 241376036
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)